Literature DB >> 7823719

Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients.

P N Wenger1, J Otten, A Breeden, D Orfas, C M Beck-Sague, W R Jarvis.   

Abstract

From 1988 to 1990, an outbreak of multidrug-resistant tuberculosis (MDR-TB) among patients, and an increased number of tuberculin-skin-test conversions among healthcare workers, occurred on the HIV ward of Jackson Memorial Hospital, Miami, Florida, USA. Measures similar to those subsequently recommended in the 1990 Centers for Disease Control and Prevention guidelines were implemented on the HIV ward by June, 1990, and in September, 1992, we evaluated the efficacy of these control measures. Among MDR-TB patients and healthcare workers with tuberculin-skin-test conversions on the HIV ward, we looked for evidence of exposure to HIV ward MDR-TB patients positive for acid-fast bacilli in sputum during initial (January-May, 1990) and follow-up (June, 1990-June, 1992) periods. Exposure before implementation of control measures to an infectious MDR-TB patient on the HIV ward was recorded in 12 of 15 (80%) MDR-TB patients during the initial period and 5 of 11 (45%) MDR-TB patients during follow-up. After implementation of control measures, no episodes of MDR-TB could be traced to contact with infectious MDR-TB patients on the HIV ward. Skin-test conversions among workers on the HIV ward declined from 7 of 25 (28%) during the initial period to 3 of 17 (18%) in the early (June, 1990-February, 1991) and 0 of 23 in the late (March, 1991-June, 1992) follow-up periods (p < 0.01). Skin-test conversions among healthcare workers were not associated with increased exposure to MDR-TB patients, and were not significantly higher among workers on the HIV ward than on a control ward without tuberculosis patients (3/27 vs 0/16). These data demonstrate that implementation of measures similar to the Centers for Disease Control and Prevention 1990 tuberculosis-control guidelines were effective in halting transmission of MDR-TB to healthcare workers and HIV-infected patients.

Entities:  

Mesh:

Year:  1995        PMID: 7823719     DOI: 10.1016/s0140-6736(95)90228-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

1.  British Thoracic Society guidelines on diagnostic flexible bronchoscopy.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Occult miliary tuberculosis in advanced HIV disease.

Authors:  E L Corbett; R N Davidson; S B Lucas; N Shetty; R F Miller
Journal:  Genitourin Med       Date:  1996-06

Review 3.  Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 4.  Mantoux (tuberculosis) testing. Evaluation of guidelines for testing in Canadian institutions.

Authors:  R E Thomas
Journal:  Can Fam Physician       Date:  1997-05       Impact factor: 3.275

5.  Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.

Authors:  Lelia H Chaisson; Marguerite Roemer; David Cantu; Barbara Haller; Alexander J Millman; Adithya Cattamanchi; J Lucian Davis
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

6.  Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures.

Authors:  Iacopo Baussano; Massimiliano Bugiani; Aurelia Carosso; Dario Mairano; Anna Pia Barocelli; Marina Tagna; Vincenza Cascio; Pavilio Piccioni; Walter Arossa
Journal:  Occup Environ Med       Date:  2006-08-15       Impact factor: 4.402

7.  Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.

Authors:  Neel R Gandhi; Darren Weissman; Prashini Moodley; Melissa Ramathal; Inga Elson; Barry N Kreiswirth; Barun Mathema; Elena Shashkina; Richard Rothenberg; Anthony P Moll; Gerald Friedland; A Willem Sturm; N Sarita Shah
Journal:  J Infect Dis       Date:  2012-11-19       Impact factor: 5.226

Review 8.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

9.  Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.

Authors:  I J Eltringham; S M Wilson; F A Drobniewski
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

10.  High risk for tuberculosis in hospital physicians, Peru.

Authors:  Nilo Bonifacio; Mayuko Saito; Robert H Gilman; Fay Leung; Nancy Cordova Chavez; Jesús Chacaltana Huarcaya; Carlos Vera Quispe
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.